Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CVD-1208S122 by Emergent BioSolutions for Bacillary Dysentery (Shigellosis): Likelihood of Approval
CVD-1208S122 is under clinical development by Emergent BioSolutions and currently in Phase I for Bacillary Dysentery (Shigellosis). According to GlobalData,...